MORE DISEASE: HOW MAJOR A FACTOR IN HIGHER UTILIZATION
更多疾病:高利用率的主要因素
基本信息
- 批准号:6154438
- 负责人:
- 金额:$ 1.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2000-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Many studies have reported large differences in age/sex adjusted rates of
hospital utilization across small areas, often leading to the conclusion
that hospitalization rates in the higher rate areas can be reduced to
those in lower "benchmark" areas. An assumption underlying these
recommendations is that age and sex adjustment has fully accounted for
differences in underlying disease in the different areas. The hypothesis
that we will examine is that there is more underlying disease in higher
rate areas: As a proxy for underlying disease, we will use rates of
treatment of an "outpatient only" basis.
We will study Medicare admission in Massachusetts in 1995 for 22 medical
conditions, 17 of which have shown in earlier work to be in the top 50% in
terms of small area variations. From our earlier work, we known that the
drive of variations in inpatient admissions are variations in a number of
individuals admitted (as opposed to re-admissions). Thus, we will focus on
individuals treated in two categories: as inpatients and as outpatients
only. We will use the 70 small geographic areas in Massachusetts
previously created. For each are and each condition, we will calculate
relative rates of individual inpatient admissions, individuals treated as
outpatients only, and individuals treated as inpatients or outpatients
only as follows: (observed number-expected number)/expected number.
Empirical Bayes (EB) techniques will be used to estimate "true" relative
rates in order to guard against the impact that extreme rates from small
areas might have on results. In the analysis, we will focus on the
correlation of inpatient and outpatient EB-estimated rates (a high
positive correlation would support the "more disease" hypothesis; a high
negative correlation the "practice style" hypothesis); R-squared,
indicating the percent of variation in inpatient rates explained by
variation in outpatient only rates; and a comparison of EB estimates of
systematic variation in individuals admitted to systematic variation in
inpatients plus outpatients. Empirical support for the "more disease"
hypothesis might shift some research focus from ways to reduce inpatient
utilization to study of the causes of more disease.
许多研究报告了年龄/性别调整后的发病率的巨大差异
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Do variations in disease prevalence limit the usefulness of population-based hospitalization rates for studying variations in hospital admissions?
疾病患病率的变化是否会限制基于人群的住院率对于研究入院变化的有用性?
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:3
- 作者:Shwartz,Michael;Pekoz,ErolA;Ash,ArleneS;Posner,MichaelA;Restuccia,JosephD;Iezzoni,LisaI
- 通讯作者:Iezzoni,LisaI
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Shwartz其他文献
Michael Shwartz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Shwartz', 18)}}的其他基金
MORE DISEASE: HOW MAJOR A FACTOR IN HIGHER UTILIZATION
更多疾病:高利用率的主要因素
- 批准号:
2871182 - 财政年份:1998
- 资助金额:
$ 1.05万 - 项目类别:
相似海外基金
Clinical Research Design, Epidemiology and Biostatistics Core
临床研究设计、流行病学和生物统计学核心
- 批准号:
10205085 - 财政年份:2017
- 资助金额:
$ 1.05万 - 项目类别:
Clinical Research Design, Epidemiology, and Biostatistics Core
临床研究设计、流行病学和生物统计学核心
- 批准号:
8948611 - 财政年份:2016
- 资助金额:
$ 1.05万 - 项目类别:
Clinical Research Design, Epidemiology and Biostatistics Core
临床研究设计、流行病学和生物统计学核心
- 批准号:
10201620 - 财政年份:2012
- 资助金额:
$ 1.05万 - 项目类别:
Clinical Research Design, Epidemiology, and Biostatistics Core
临床研究设计、流行病学和生物统计学核心
- 批准号:
10213753 - 财政年份:2012
- 资助金额:
$ 1.05万 - 项目类别:
Generalisation of the Fractional Polynomial procedure for semi-continuous variables in epidemiology and clinical research
流行病学和临床研究中半连续变量的分数多项式程序的推广
- 批准号:
203062028 - 财政年份:2011
- 资助金额:
$ 1.05万 - 项目类别:
Research Grants
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)
糖尿病干预和并发症流行病学 (EDIC) 研究临床研究中心(合作 U01)继续有限竞争
- 批准号:
10207609 - 财政年份:2011
- 资助金额:
$ 1.05万 - 项目类别:
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)
糖尿病干预和并发症流行病学 (EDIC) 研究临床研究中心(合作 U01)继续有限竞争
- 批准号:
9557690 - 财政年份:2011
- 资助金额:
$ 1.05万 - 项目类别:
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)
糖尿病干预和并发症流行病学 (EDIC) 研究临床研究中心(合作 U01)继续有限竞争
- 批准号:
9976328 - 财政年份:2011
- 资助金额:
$ 1.05万 - 项目类别:
K24 Clinical Research in Antimicrobial Resistance and Hospital Epidemiology
K24 抗菌药物耐药性和医院流行病学临床研究
- 批准号:
8416369 - 财政年份:2009
- 资助金额:
$ 1.05万 - 项目类别:
K24 Clinical Research in Antimicrobial Resistance and Hospital Epidemiology
K24 抗菌药物耐药性和医院流行病学临床研究
- 批准号:
7659719 - 财政年份:2009
- 资助金额:
$ 1.05万 - 项目类别:














{{item.name}}会员




